ATXS NASDAQ
Astria Therapeutics, Inc.
1W: +1.5%
1M: +3.7%
3M: +73.6%
1Y: +43.1%
3Y: -11.6%
5Y: -8.3%
$12.58
Last traded 2025-12-31 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$1M
Revenue
+0.0% YoY
$-124M
Net Income
-24.0% YoY
$-120M
Free Cash Flow
-27.4% YoY
100.0%
Gross Margin
-4830.6%
Op. Margin
-4482.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-43.1%
ROA-39.2%
ROIC-1079.4%
Valuation
P/E-11.2
P/B3.1
EV/EBITDA-1.5
Leverage
Debt/Equity0.02
Current Ratio10.78
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z1.97
Beneish M0.00